ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,858,000 | +43.2% | 41,516 | -8.3% | 0.00% | 0.0% |
| Q3 2021 | $2,695,000 | -26.8% | 45,255 | -16.1% | 0.00% | 0.0% |
| Q2 2021 | $3,680,000 | +12.7% | 53,944 | +14.6% | 0.00% | 0.0% |
| Q1 2021 | $3,266,000 | +16.6% | 47,075 | +29.1% | 0.00% | 0.0% |
| Q4 2020 | $2,800,000 | -8.8% | 36,459 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $3,070,000 | +12.2% | 41,032 | -5.6% | 0.00% | 0.0% |
| Q2 2020 | $2,735,000 | -69.6% | 43,451 | -79.7% | 0.00% | -75.0% |
| Q1 2020 | $8,991,000 | +155.9% | 214,075 | +176.7% | 0.00% | +300.0% |
| Q4 2019 | $3,513,000 | -63.0% | 77,362 | -62.7% | 0.00% | -50.0% |
| Q3 2019 | $9,492,000 | -27.6% | 207,386 | -7.3% | 0.00% | -33.3% |
| Q2 2019 | $13,111,000 | +4792.2% | 223,619 | +3642.0% | 0.00% | – |
| Q1 2019 | $268,000 | -97.8% | 5,976 | -97.7% | 0.00% | -100.0% |
| Q3 2018 | $11,954,000 | +127.7% | 259,760 | +115.8% | 0.00% | +100.0% |
| Q2 2018 | $5,249,000 | -51.3% | 120,391 | -55.9% | 0.00% | -50.0% |
| Q1 2018 | $10,776,000 | +13.3% | 272,799 | -2.6% | 0.00% | +33.3% |
| Q4 2017 | $9,515,000 | +533.1% | 280,076 | +375.2% | 0.00% | +200.0% |
| Q3 2017 | $1,503,000 | – | 58,936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |